Anhui Huaertai Chemical Co.Ltd(001217) independent director
Independent opinions on relevant proposals of the fifth meeting of the Fifth Board of directors
In accordance with the relevant provisions of the rules for independent directors of listed companies, the stock listing rules of Shenzhen Stock Exchange, the self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board and the guidelines for corporate governance of listed companies of China Securities Regulatory Commission, we, as independent directors of Anhui Huaertai Chemical Co.Ltd(001217) (hereinafter referred to as the “company”), are, After reviewing the proposals of the 5th meeting of the 5th board of directors of the company, the independent opinions on the relevant proposals of the 5th meeting of the 5th board of directors are as follows:
1、 Independent opinions on using some idle self owned funds for cash management
After examination, we believe that the company’s use of some idle self owned funds for cash management this time complies with the relevant provisions of the stock listing rules of Shenzhen Stock Exchange, the self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board, the articles of Association and other relevant provisions, and has fulfilled the necessary legal approval procedures. On the premise of ensuring the normal operation and capital safety of the company, use the temporarily idle self owned funds for cash management, increase the capital income, and better realize the preservation and appreciation of the company’s funds. There is no damage to the interests of the company and all shareholders, especially small and medium-sized shareholders. The decision-making procedures are legal and effective.
To sum up, we agree that the company uses idle self owned funds with a maximum amount of no more than 500 million yuan (including 500 million yuan) for cash management. It is agreed to submit the matter to the first extraordinary general meeting of shareholders of the company in 2022 for deliberation.
(no text below this page)
(there is no text on this page, which is the signature page of Anhui Huaertai Chemical Co.Ltd(001217) independent director’s independent opinions on relevant proposals of the fifth meeting of the Fifth Board of directors) signature of independent director: Shen Jiefeng (signature):
February 8, 2022 (there is no text on this page, which is the signature page of Anhui Huaertai Chemical Co.Ltd(001217) independent directors’ independent opinions on relevant proposals of the fifth meeting of the Fifth Board of directors) signature of independent director: Chen Jun (signature):
February 8, 2022 (there is no text on this page, which is the signature page of Anhui Huaertai Chemical Co.Ltd(001217) independent directors’ independent opinions on relevant proposals of the fifth meeting of the Fifth Board of directors) signature of independent director: Chen Guanglei (signature):
February 8, 2022
